J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Corporate Action-Board to consider Dividend
Recommendation of Final dividend of Rs. 6.75 per share of FV Re. 1(675%) for the FY 2023-2417-05-2024
17-05-2024
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Board Meeting Outcome for Outcome Of Meeting Of Board Of Directors - Audited Standalone And Consolidated Financial Results For The Year Ended On March 31, 2024 Accompanied By Auditors' Report
Audited standalone and Consolidated financial results for the year ended on March 31, 2024 accompanied by Auditors' Report17-05-2024
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report for the financial year ended on March 31, 202415-05-2024
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Investors/ Analysts call with Management13-05-2024
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Allotment of equity shares on exercise of stock options pursuant to Employee Stock Option Scheme11-05-2024
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Board Meeting Intimation for (I) Consideration And Approval Of The Audited Financial Results For The Year And Quarter Ended On March 31, 2024; (Ii) Consideration And Recommendation Of Dividend On Equity Shares Of The Company, If Any, Subject To Approval Of Shareholders
J.B.CHEMICALS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/05/2024 ,inter alia, to consider and approve (i) the audited financial results for the year and quarter ended on March 31, 2024; (ii) Consider and recommend Dividend on equity shares of the Company, if any, subject to approval of shareholders10-05-2024
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements), Regulations, 2015
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 - Receipt of Order30-04-2024
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements), Regulations, 2015
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 - Receipt of Order30-04-2024
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements), Regulations, 2015
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 - Receipt of Order30-04-2024
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Disclosure under Regulation 30 of the SEBI (listings Obligations and Disclosure Requirements) Regulations, 2015 - Updated29-04-2024